IP Verse

Liver-Specific Nucleic Acid Regulatory Elements And Methods And Use Thereof - EP2282764

The patent EP2282764 was granted to Life Sciences Research Partners VZW on Jun 12, 2024. The application was originally filed on Apr 21, 2009 under application number EP09735371A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2282764

LIFE SCIENCES RESEARCH PARTNERS VZW
Application Number
EP09735371A
Filing Date
Apr 21, 2009
Status
Patent Maintained As Amended
May 10, 2024
Grant Date
Jun 12, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEApr 24, 2020CARPMAELS & RANSFORDADMISSIBLE
PFIZERApr 23, 2020PFIZERADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO0198482
DESCRIPTIONWO9511308
EXAMINATIONUS2001010815
INTERNATIONAL-SEARCH-REPORTUS2006189561
INTERNATIONAL-SEARCH-REPORTWO0198482
OPPOSITIONUS10149914
OPPOSITIONUS10471157
OPPOSITIONUS2001010815
OPPOSITIONUS2006189561
OPPOSITIONUS9617548
OPPOSITIONWO0198482
OPPOSITIONWO2009102085

Non-Patent Literature (NPL) Citations (80) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- AUSUBEL ET AL., Current Protocols in Molecular Biology, JOHN WILEY & SONS, (1999), vol. 47-
DESCRIPTION- BARAJAS M; MAZZOLINI G; GENOVE G; BILBAO R; NARVAIZA; SCHMITZ V; SANGRO B; MELERO; QIAN C; PRIETO J, "Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12", HEPATOLOGY, (200101), vol. 33, no. 1, pages 52 - 61-
DESCRIPTION- BERGER; KIMMEL, Methods in Enzymology: Guide to Molecular Cloning Techniques, ACADEMIC PRESS, INC., (1987), vol. 152-
DESCRIPTION- BUDKER V; ZHANG G; KNECHTLE S; WOLFF JA, "Naked DNA delivered intraportally expresses efficiently in hepatocytes", GENE THER., (199607), vol. 3, no. 7, pages 593 - 8-
DESCRIPTION- COSTA RH; GRAYSON DR; DARNELL JE JR, "Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes", MOL CELL BIOL., (198904), vol. 9, no. 4, pages 1415 - 25-
DESCRIPTION- COSTA RH; LAI E; DARNELL JE JR, "Transcriptional control of the mouse prealbumin (transthyretin) gene: both promoter sequences and a distinct enhancer are cell specific", MOL CELL BIOL., (198612), vol. 6, no. 12, pages 4697 - 708, XP002453975-
DESCRIPTION- FERRY N; HEARD JM, "Liver-directed gene transfer vectors", HUM GENE THER., (19980920), vol. 9, no. 14, pages 1975 - 81, XP000874072-
DESCRIPTION- GAO GP; ALVIRA MR; WANG L; CALCEDO R; JOHNSTON J; WILSON JM, "Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy", PROC NATL ACAD SCI, (2002), vol. 99, pages 11854 - 9-
DESCRIPTION- GHOSH SS; TAKAHASHI M; THUMMALA NR; PARASHAR B; CHOWDHURY NR; CHOWDHURY JR, "Liver- directed gene therapy: promises, problems and prospects at the turn of the century", J HEPATOL., (2000), vol. 32, no. 1, pages 238 - 52-
DESCRIPTION- "Guide to Molecular Cloning Techniques", BERGER SL; KIMMEL AR, Methods in Enzymology, ACADEMIC PRESS, INC., (1987), vol. 152-
DESCRIPTION- KEL AE; G6SSLING E; REUTER; CHEREMUSHKIN E; KEL-MARGOULIS OV; WINGENDER E, "MATCH: A tool for searching transcription factor binding sites in DNA sequences", NUCLEIC ACIDS RES., (20030701), vol. 31, no. 13, pages 3576 - 9-
DESCRIPTION- KURIYAMA S; YOSHIKAWA M; ISHIZAKA S; TSUJII T; IKENAKA K; KAGAWA T; MORITA N; MIKOSHIBA K, "A potential approach for gene therapy targeting hepatoma using a liver-specific promoter on a retroviral vector", CELL STRUCT FUNCT., (199112), vol. 16, no. 6, pages 503 - 10, XP002089627-
DESCRIPTION- LEMKEN ML; WYBRANIETZ WA; SCHMIDT U; GRAEPLER F; ARMEANU S; BITZER M; LAUER UM, "Expression liver-directed genes by employing synthetic transcriptional control units", WORLD J GASTROENTEROL., (20050914), vol. 11, no. 34, pages 5295 - 302, XP009136908-
DESCRIPTION- LE M; OKUYAMA T; CAI SR; KENNEDY SC; BOWLING WM; FLYE MW; PONDER KP, "Therapeutic levels of functional human factor X in rats after retroviral-mediated hepatic gene therapy", BLOOD, (19970215), vol. 89, no. 4, pages 1254 - 9-
DESCRIPTION- MANNO CS; PIERCE GF; ARRUDA VR; GLADER B; RAGNI M; RASKO JJ; OZELO MC; HOOTS K; BLATT P; KONKLE B, "Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response", NAT MED., (200603), vol. 12, no. 3, pages 342 - 7, XP002578131-
DESCRIPTION- MANZINI S; VARGIOLU A; STEHLE IM; BACCI ML; CERRITO MG; GIOVANNONI R; ZANNONI A; BIANCO MR; FORNI M; DONINI P, "Genetically modified pigs produced with a nonviral episomal vector", PROC NATL ACAD SCI U S A., (20061121), vol. 103, no. 47, pages 17672 - 7-
DESCRIPTION- MIAO CH; OHASHI K; PATIJN GA; MEUSE L; YE X; THOMPSON AR; KAY MA, "Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro", MOL THER., (200006), vol. 1, no. 6, pages 522 - 32, XP002550493-
DESCRIPTION- MINGOZZI F; LIU YL; DOBRZYNSKI E; KAUFHOLD A; LIU JH; WANG Y; ARRUDA VR; HIGH KA; HERZOG RW, "Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer", J CLIN INVEST, (2003), vol. 111, pages 1347 - 56-
DESCRIPTION- PAPATSENKO DA; MAKEEV VJ; LIFANOV AP; REGNIER M; NAZINA AG; DESPLAN C, "Extraction of functional binding sites from unique regulatory regions: the Drosophila early developmental enhancers", GENOME RES., (200203), vol. 12, no. 3, pages 470 - 81-
DESCRIPTION- PASTORE L; MORRAL N; ZHOU H; GARCIA R; PARKS RJ; KOCHANEK S; GRAHAM FL; LEE B; BEAUDET AL, "Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors", HUM GENE THER., (19990720), vol. 10, no. 11, pages 1773 - 81-
DESCRIPTION- PILPEL Y; SUDARSANAM P; CHURCH GM, "Identifying regulatory networks by combinatorial analysis of promoter elements", NAT GENET., (200110), vol. 29, no. 2, pages 153 - 9-
DESCRIPTION- PRIETO J; HERRAIZ M; SANGRO B; QIAN C; MAZZOLINI G; MELERO; RUIZ J, "The promise of gene therapy in gastrointestinal and liver diseases", GUT, (2003), vol. 52, no. 11, pages II49 - II54-
DESCRIPTION- "Retrovirus packaging cells", MILLER AD, Hum Gene Ther., SPRING, (1990), vol. 1, pages 5 - 14-
DESCRIPTION- SCHAGEN FH; OSSEVOORT M; TOES RE; HOEBEN RC, "Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion", CRIT REV ONCOL HEMATOL., (200404), vol. 50, no. 1, pages 51 - 70-
DESCRIPTION- SHEN RF; CLIFT SM; DEMAYO JL; SIFERS RN; FINEGOLD MJ; WOO SL, "Tissue-specific regulation of human alpha 1-antitrypsin gene expression in transgenic mice", DNA, (198903), vol. 8, no. 2, pages 101 - 8-
DESCRIPTION- SIMONET WS; BUCAY N; LAUER SJ; TAYLOR JM, "A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice", J BIOL CHEM., (19930415), vol. 268, no. 11, pages 8221 - 9, XP000604831-
DESCRIPTION- TENENBAUM L; LEHTONEN E; MONAHAN PE, "Evaluation of risks related to the use of adeno- associated virus-based vectors", CURR GENE THER, (2003), vol. 3, pages 545 - 565-
DESCRIPTION- VANDENDRIESSCHE T; THORREZ L; NALDINI L; FOLLENZI A; MOONS L; BERNEMAN Z; COLLEN D; CHUAH MK, "Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo", BLOOD, (20020801), vol. 100, no. 3, pages 813 - 22-
DESCRIPTION- VILLA E; GROTTOLA A; BUTTAFOCO P; COLANTONI A; BAGNI A; FERRETTI; CREMONINI C; BERTANI H; MANENTI F, "High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial", AM J GASTROENTEROL., (200110), vol. 96, no. 10, pages 2973 - 7-
DESCRIPTION- WOOD M; PERROTTE P; ONISHI E; HARPER ME; DINNEY C; PAGLIARO L; WILSON DR, "Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse", CANCER GENE THER., (199907), vol. 6, no. 4, pages 367 - 72-
DESCRIPTION- XIA D; ZHANG MM; YAN LN, "Recent advances in liver-directed gene transfer vectors", HEPATOBILIARY PANCREAT DIS INT., (200408), vol. 3, no. 3, pages 332 - 6-
DESCRIPTION- YAMADA T; IWASAKI Y; TADA H; IWABUKI H; CHUAH MK; VANDENDRIESSCHE T; FUKUDA H; KONDO A; UEDA M; SENO M, "Nanoparticles for the delivery of genes and drugs to human hepatocytes", NAT BIOTECHNOL., (200308), vol. 21, no. 8, pages 885 - 90-
DESCRIPTION- YULL FE; WALLACE RM; CLARK AJ, "Restricted tissue-specific but correct developmental expression mediated by a short human alpha 1AT promoter fragment in transgenic mice", TRANSGENIC RES., (199501), vol. 4, no. 1, pages 70 - 4-
DESCRIPTION- MIAO CH; THOMPSON AR; LOEB K; YE X, "Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo", MOL THER., (200106), vol. 3, no. 6, doi:doi:10.1006/mthe.2001.0333, pages 947 - 57, XP055143164
DESCRIPTION- TRAPNELL BC, "Adenoviral vectors for gene transfer", ADV. DRUG DEL. REV., (1993), vol. 12, doi:doi:10.1016/0169-409X(93)90059-D, pages 185 - 199, XP023744816
DESCRIPTION- GEHRKE S; JÉRÔME V; MÜLLER R, "Chimeric transcriptional control units for improved liver-specific transgene expression", GENE, (20031211), vol. 322, doi:doi:10.1016/j.gene.2003.08.010, pages 137 - 43, XP004477017
DESCRIPTION- KRAMER MG; BARAJAS M; RAZQUIN N; BERRAONDO P; RODRIGO M; WU C; QIAN C; FORTES P; PRIETO J, "In vitro and in vivo comparative study of chimeric liver-specific promoters", MOL THER., (200303), vol. 7, no. 3, doi:doi:10.1016/s1525-0016(02)00060-6, pages 375 - 85, XP002624075
DESCRIPTION- SNYDER RO; MIAO C; MEUSE L; TUBB J; DONAHUE BA; LIN HF; STAFFORD DW; PATEL S; THOMPSON AR; NICHOLS T, "Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors", NAT MED., (199901), vol. 5, no. 1, doi:doi:10.1038/13518, pages 64 - 70, XP002190250
DESCRIPTION- BROWN BD; VENNERI MA; ZINGALE A; SERGI L; NALDINI L, "Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer", NAT MED., (200605), vol. 12, no. 5, doi:doi:10.1038/nm1398, pages 585 - 91, XP002652777
DESCRIPTION- LIU F; SONG Y; LIU D, "Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA", GENE THER., (199907), vol. 6, no. 7, doi:doi:10.1038/sj.gt.3300947, pages 1258 - 66, XP009036645
DESCRIPTION- JENKE AC; STEHLE IM; HERRMANN F; EISENBERGER T; BAIKER A; BODE J; FACKELMAYER FO; LIPPS HJ, "Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome", PROC NATL ACAD SCI USA., (20040803), vol. 101, no. 31, doi:doi:10.1073/pnas.0401355101, pages 11322 - 7, XP002497602
DESCRIPTION- KAY MA; BALEY P; ROTHENBERG S; LELAND F; FLEMING L; PONDER KP; LIU T; FINEGOLD M; DARLINGTON G; POKORNY W, "Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes", PROC NATL ACAD SCI USA., (19920101), vol. 89, no. 1, doi:doi:10.1073/pnas.89.1.89, pages 89 - 93, XP055442652
DESCRIPTION- CRISTIANO RJ; SMITH LC; KAY MA; BRINKLEY BR; WOO SL, "Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex", PROC NATL ACAD SCI USA., (19931215), vol. 90, no. 24, doi:doi:10.1073/pnas.90.24.11548, pages 11548 - 52, XP001042145
DESCRIPTION- KISTNER A; GOSSEN M; ZIMMERMANN F; JERECIC J; ULLMER C; LUBBERT H; BUJARD H, "Doxycycline- mediated quantitative and tissue-specific control of gene expression in transgenic mice", PROC NATL ACAD SCI USA., (19961001), vol. 93, no. 20, doi:doi:10.1073/pnas.93.20.10933, pages 10933 - 8, XP002110022
DESCRIPTION- FOLLENZI A; SABATINO G; LOMBARDO A; BOCCACCIO C; NALDINI L, "Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors", HUM GENE THER., (20020120), vol. 13, no. 2, doi:doi:10.1089/10430340252769770, pages 243 - 60, XP002980267
DESCRIPTION- ZHANG G; BUDKER V; WOLFF JA, "High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA", HUM GENE THER., (19990701), vol. 10, no. 10, doi:doi:10.1089/10430349950017734, pages 1735 - 7, XP002201559
DESCRIPTION- VANDENDRIESSCHE T; THORREZ L; ACOSTA-SANCHEZ A; PETRUS; WANG L; MA L; DE WAELE L; IWASAKI Y; GILLIJNS V; WILSON JM, "Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy", J THROMB HAEMOST., (200701), vol. 5, no. 1, doi:doi:10.1111/j.1538-7836.2006.02220.x, pages 16 - 24, XP002636191
DESCRIPTION- CHOWDHURY JR; GROSSMAN M; GUPTA S; CHOWDHURY NR; BAKER JR JR; WILSON JM, "Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits", SCIENCE, (19911220), vol. 254, no. 5039, doi:doi:10.1126/science.1722351, pages 1802 - 5, XP002062182
DESCRIPTION- NALDINI L; B16MER U; GALLAY P; ORY D; MULLIGAN R; GAGE FH; VERMA IM; TRONO D, "In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector", SCIENCE, (19960412), vol. 272, no. 5259, doi:doi:10.1126/science.272.5259.263, pages 263 - 7, XP000583652
DESCRIPTION- BROWN BD; CANTORE A; ANNONI A; SERGI LS; LOMBARDO A; DELLA VALLE P; D'ANGELO A; NALDINI L, "A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice", BLOOD, (20071215), vol. 110, no. 13, doi:doi:10.1182/blood-2007-03-078493, pages 4144 - 52, XP002471753
DESCRIPTION- DE BLESER P; HOOGHE B; VLIEGHE D; VAN ROY F, "A distance difference matrix approach to identifying transcription factors that regulate differential gene expression", GENOME BIOL., (2007), vol. 8, no. 5, doi:doi:10.1186/gb-2007-8-5-r83, page R83, XP021031219
EXAMINATION- DE SIMONE ET AL, "Cis-and trans-acting elements responsible for the cell-specific expression of the human Al-antitrypsin gene", THE EMBO JOURNAL, (19870101), vol. 6, pages 2759 - 2766, XP055452704-
EXAMINATION- SOPHIE VAN LINTHOUT ET AL, "Effect of Promoters and Enhancers on Expression, Transgene DNA Persistence, and Hepatotoxicity After Adenoviral Gene Transfer of Human Apolipoprotein A-I", HUMAN GENE THERAPY, (20020501), vol. 13, no. 7, doi:10.1089/10430340252899000, ISSN 1043-0342, pages 829 - 840, XP055050768
INTERNATIONAL-SEARCH-REPORT[ ] - "Human alpha-1 antitrypsin (hAAT) liver-specific promoter DNA.", Geneseq, (20061019), Database accession no. AEJ93089, URL: EBI-
INTERNATIONAL-SEARCH-REPORT- NATHWANI AMIT C ET AL, "Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver.", BLOOD 1 APR 2006, (20060401), vol. 107, no. 7, ISSN 0006-4971, pages 2653 - 2661, XP002534783 [X] 1-4,7,9-19 * page 2654, column 2 - page 2655, column 1 * * figure 1 * * page 2660, column 1, paragraph 1 * [Y] 8
OPPOSITION- Alignment of hAAT regulatory sequences-
OPPOSITION- DE BLESER et al., "A distance difference matrix approach to identifying transcription factors that regulate differential gene expression", Genome Biology, (20070516), vol. 8, no. 5, page R83-
OPPOSITION- DENTE L et al., "pEMBL: a new family of single stranded plasmids", Nucleic Acids Research, (19830000), vol. 11, no. 6, pages 1645 - 55, XP002393931-
OPPOSITION- DE SIMONE et al., "A negative regulatory element in the promoter of the human al-antitrypsin gene", Nucleic Acids Research, (19891125), vol. 17, no. 22, pages 9407 - 9415-
OPPOSITION- DE SIMONE et al., "A negative regulatory element in the promoter of the human al-antitrypsin gene", Nucleic Acids Research, (19891125), vol. 17, no. 22, pages 9407 - 9415, XP055706706-
OPPOSITION- DE SIMONE et al., "Cis-and trans-acting elements responsible for the cell-specific expression of the human Al-antitrypsin gene", THE EMBO JOURNAL, (19870101), vol. 6, pages 2759 - 2766-
OPPOSITION- DE SIMONE et al., "Cis-and trans-acting elements responsible for the cell-specific expression of the human Al-antitrypsin gene", THE EMBO JOURNAL, (19870101), vol. 6, pages 2759 - 2766, XP055452704-
OPPOSITION- HUNT AG et al., "Arabidopsis mRNA polyadenylation machinery: comprehensive analysis of protein-protein interactions and gene expression profiling", BMC Genomics, (20080514), vol. 9, page 220, XP021032952-
OPPOSITION- MANNO CS et al., "Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response", Nat Med., (20060300), vol. 12, no. 3, pages 342 - 7, XP002578131-
OPPOSITION- NATHWANI AMIT C et al., "Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver", BLOOD, (20060401), vol. 107, no. 7, pages 2653 - 2661-
OPPOSITION- SOPHIE VAN LINTHOUT et al., "Effect of Promoters and Enhancers on Expression, Transgene DNA Persistence, and Hepatotoxicity After Adenoviral Gene Transfer of Human Apolipoprotein A-I", HUMAN GENE THERAPY, (20020501), vol. 13, no. 7, pages 829 - 840-
OPPOSITION- Vincenzo De Simone, Cortese Riccardo, "A negative regulatory element in the promoter of the human oal-antitrypsin gene", Nucleic Acids Research, (19891125), vol. 17, no. 22, pages 9407 - 9415, XP055706706-
OPPOSITION- WOLFF J et al., Gene Therapeutics, Basel, (19940000), pages 61 - 63, XP055736544-
OPPOSITION- V. De Simone, G. Ciliberto, E. Hardon, G. Paonessa, F. Palla, L. Lundberg, R. Cortese, "Cis‐ and trans‐acting elements responsible for the cell‐specific expression of the human alpha 1‐antitrypsin gene.", The EMBO Journal, European Molecular Biology Organization, (19870901), vol. 9, no. 6, doi:10.1002/j.1460-2075.1987.tb02570.x, ISSN 0261-4189, pages 2759 - 2766, XP055452702
OPPOSITION- P Monaci, Et Al, "Two different liver-specific factors stimulate in vitro transcription from the human alpha 1-antitrypsin promoter", EMBO, (19880101), vol. 7, no. 7, pages 2075 - 2087, XP055716322
OPPOSITION- C. Yan, R.H. Costa, J.E. Darnell, J.D. Chen, T.A. Van Dyke, "Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice.", The EMBO Journal, European Molecular Biology Organization, (19900301), vol. 9, no. 3, doi:10.1002/j.1460-2075.1990.tb08184.x, ISSN 0261-4189, pages 869 - 878, XP055716369
OPPOSITION- KRAMER MG et al., "In vitro and in vivo comparative study of chimeric liver-specific promoters", Mol Ther., (20030300), vol. 7, no. 3, doi:10.1016/s1525-0016(02)00060-6, pages 375 - 85, XP002624075
OPPOSITION- WU Z et al., "Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose", Mol Ther., (20080200), vol. 16, no. 2, doi:10.1038/sj.mt.6300355, pages 280 - 9, XP055097643
OPPOSITION- SOPHIE VAN LINTHOUT et al., "Effect of Promoters and Enhancers on Expression, Transgene DNA Persistence, and Hepatotoxicity After Adenoviral Gene Transfer of Human Apolipoprotein A-I", HUMAN GENE THERAPY, (20020501), vol. 13, no. 7, pages 829 - 840, XP055050768
OPPOSITION- Mark D. Marsden, R. E. K. Fournier, "Chromosomal Elements Regulate Gene Activity and Chromatin Structure of the Human Serpin Gene Cluster at 14q32.1", MOLECULAR AND CELLULAR BIOLOGY, American Society for Pharmacology and Experimental Therapeutics, US, US, (20030515), vol. 23, no. 10, doi:10.1128/MCB.23.10.3516-3526.2003, ISSN 0270-7306, pages 3516 - 3526, XP055716332
OPPOSITION- NATHWANI AC et al., "Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver", Blood, (20060401), vol. 107, no. 7, doi:10.1182/blood-2005-10-4035, pages 2653 - 61, XP002534783
OPPOSITION- NATHWANI AMIT C et al., "Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver", BLOOD, (20060401), vol. 107, no. 7, pages 2653 - 2661, XP002534783
OPPOSITION- Maithao Le, Torayuki Okuyama, Shi-Rong Cai, Susan C. Kennedy, William M. Bowling, M. Wayne Flye, Katherine Parker Ponder, "Abstract", BLOOD, The American Society of Hematology, US, US, (19970215), vol. 89, no. 4, doi:10.1182/blood.V89.4.1254, ISSN 0006-4971, pages 1254 - 1259, XP055716329
OPPOSITION- DE BLESER et al., "A distance difference matrix approach to identifying transcription factors that regulate differential gene expression", Genome Biology, (20070516), vol. 8, no. 5, page R83, XP021031219
OPPOSITION- Kat S. Moore, Marieke Von Lindern, "RNA Binding Proteins and Regulation of mRNA Translation in Erythropoiesis", Frontiers in Physiology, Frontiers Research Foundation, CH, CH, (20180124), vol. 9, doi:10.3389/fphys.2018.00910, ISSN 1664-042X, XP055716375

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents